Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-08
1999-11-30
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514324, A61K 31495, A61K 31445
Patent
active
059943572
ABSTRACT:
A method of treating patients suffering from interstitial cystitis comprising the administration to such patients of an inhibitor of neurohormonal activation of mast cell secretion selected from the group of histamine-1 receptor antagonists consisting of azatadine, azelastine, cetirizine, hydroxyzine and ketotifen, by oral, parenteral, transmucosal, and transdermal routes of administration.
REFERENCES:
patent: 4594351 (1986-06-01), Scott
Grupe et al, Agents Actions Suppl., AAS (Trends Inflammation Res. 2), pp. 273-287, 1982.
Grupe et al 98 CA: 27515 G 1983.
Merck Manual of Diagnosis & Therapy 14.sup.th Ed 1982 pp. 1569-1570.
Tozzi et al. 82 CA:68235d 1975.
Engel et al. 115 CA: 142251z 1990.
Coulie et al. 115 CA 421f 1991.
Nouakova et al. 107CA: 91379x.
The Merck Manual of Diagnosis & Therapy 14.sup.th ed.
Grupe et al 98 CA:27515 G 1983.
LandOfFree
Method of treatment for interstitial cystitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treatment for interstitial cystitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment for interstitial cystitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1672934